Chromatographic Release Profile of ActivePharmaceutical Ingredients of Synthesized Prodrug and Codrug of Aspirin+Paracetamol and Indomethacin+Paracetamol in Physiological Fluids

Debojyoti Basu, Divyesh Sharma, D. Sen
{"title":"Chromatographic Release Profile of ActivePharmaceutical Ingredients of Synthesized Prodrug and Codrug of Aspirin+Paracetamol and Indomethacin+Paracetamol in Physiological Fluids","authors":"Debojyoti Basu, Divyesh Sharma, D. Sen","doi":"10.21767/2321-547X.1000017","DOIUrl":null,"url":null,"abstract":"Prodrug is the precursor of drug which is made by derivatization of the same to enhance the bioavailability by pharmacokinetics, lipid solubility by partition coefficient and increase the physicochemical and biochemical parameters by pharmacodynamics. All two prodrugs showed different logP values and molecular weights according to the solubility parameters and electronegativity: logP profile: Prodrug-B>Prodrug-A; molecular weight profile: Prodrug-B>Prodrug-A. The main side effect of NSAID is gastric acidity due to release of free H+ because all NSAIDs have free-COOH (carboxylic acid) group which act by competitive inhibition of cyclooxygenase enzyme (COX1/COX2). Here the target of this project has been designed in such a way to convert the free –COOH/–OH of API (aspirin/paracetamol) into prodrug of two ester (–COO–) and one amide (– CONH–) linkage (Prodrug-A) and one ester and two amide linkage (Prodrug-B) which releases free API after metabolic hydrolysis in acidic pH: 1-4 and alkaline pH: 7-9. Since the prodrugs are repository forms so chances to release gastric acid has been minimized due to non-availability of free-COOH group in stomach. The biotransformation of active drug from prodrug takes such a time in stomach that all goes upto duodenum and then ileum of small intestine that chances of acidity is reduced. Finally all prodrugs go to small intestine where alkaline pH starts so gastric acidity is reduced. Since all two prodrugs are made of two NSAID: Prodrug-A (logP=2.15) releases Aspirin and Paracetamol, Prodrug-B (logP=3.94) releases Indomethacin and Paracetamol which shows distinct two Rt values in HPLC both in acidic an alkaline hydrolysis and these Rt values of Prodrugs match with the individual API components so the purpose of our goal has been completed successfully. The pH of gastric acid varies from 1.5- 3.5 in the human stomach lumen, the acidity being maintained by the proton pump H+/K+ ATPase. So the pattern for acid hydrolysis was adjusted at pH=3- 3.5 by HCl. The pH of intestine varies from 5.6-6.9, so the pattern for alkaline hydrolysis was adjusted at pH=7.0-8.0 by NaOH. In case of codrug which is made by non-covalent interactions such as hydrogen bonding, ionic interactions, Van der Waals interactions and π-interactions between two APIs, so the release of parent molecule will be faster than prodrug both in acidic as well as in alkaline pH because prodrug is made by covalent bonding between two APIs. log P profile: Codrug-B (3.42)>Codrug-A (1.55); molecular weight profile: Codrug-B (508.94g)>Codrug-A (331.31g).","PeriodicalId":7704,"journal":{"name":"American Journal of Advanced Drug Delivery","volume":"116 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Advanced Drug Delivery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21767/2321-547X.1000017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Prodrug is the precursor of drug which is made by derivatization of the same to enhance the bioavailability by pharmacokinetics, lipid solubility by partition coefficient and increase the physicochemical and biochemical parameters by pharmacodynamics. All two prodrugs showed different logP values and molecular weights according to the solubility parameters and electronegativity: logP profile: Prodrug-B>Prodrug-A; molecular weight profile: Prodrug-B>Prodrug-A. The main side effect of NSAID is gastric acidity due to release of free H+ because all NSAIDs have free-COOH (carboxylic acid) group which act by competitive inhibition of cyclooxygenase enzyme (COX1/COX2). Here the target of this project has been designed in such a way to convert the free –COOH/–OH of API (aspirin/paracetamol) into prodrug of two ester (–COO–) and one amide (– CONH–) linkage (Prodrug-A) and one ester and two amide linkage (Prodrug-B) which releases free API after metabolic hydrolysis in acidic pH: 1-4 and alkaline pH: 7-9. Since the prodrugs are repository forms so chances to release gastric acid has been minimized due to non-availability of free-COOH group in stomach. The biotransformation of active drug from prodrug takes such a time in stomach that all goes upto duodenum and then ileum of small intestine that chances of acidity is reduced. Finally all prodrugs go to small intestine where alkaline pH starts so gastric acidity is reduced. Since all two prodrugs are made of two NSAID: Prodrug-A (logP=2.15) releases Aspirin and Paracetamol, Prodrug-B (logP=3.94) releases Indomethacin and Paracetamol which shows distinct two Rt values in HPLC both in acidic an alkaline hydrolysis and these Rt values of Prodrugs match with the individual API components so the purpose of our goal has been completed successfully. The pH of gastric acid varies from 1.5- 3.5 in the human stomach lumen, the acidity being maintained by the proton pump H+/K+ ATPase. So the pattern for acid hydrolysis was adjusted at pH=3- 3.5 by HCl. The pH of intestine varies from 5.6-6.9, so the pattern for alkaline hydrolysis was adjusted at pH=7.0-8.0 by NaOH. In case of codrug which is made by non-covalent interactions such as hydrogen bonding, ionic interactions, Van der Waals interactions and π-interactions between two APIs, so the release of parent molecule will be faster than prodrug both in acidic as well as in alkaline pH because prodrug is made by covalent bonding between two APIs. log P profile: Codrug-B (3.42)>Codrug-A (1.55); molecular weight profile: Codrug-B (508.94g)>Codrug-A (331.31g).
合成阿司匹林+扑热息痛和吲哚美辛+扑热息痛前药、副药有效药物成分在生理体液中的色谱释放谱
前药是由原药衍生而成的药物前体,通过药代动力学提高生物利用度,通过配分系数提高脂溶性,通过药效学提高理化生化参数。根据溶解度参数和电负性,两种前药均表现出不同的logP值和分子量:logP谱:Prodrug-B>Prodrug-A;分子量谱:Prodrug-B;非甾体抗炎药的主要副作用是释放游离H+导致胃酸变酸,因为所有非甾体抗炎药都含有游离羧酸基团,其作用是竞争性抑制环加氧酶(COX1/COX2)。本课题的目标是将API(阿司匹林/扑热息痛)中游离的- cooh / - oh转化为两酯(- coo -)和一酰胺(- CONH -)键的前药(prodrug - a)和一酯两酰胺键(prodrug - b),在酸性pH: 1-4和碱性pH: 7-9下代谢水解释放游离API。由于前药是储存库形式,因此释放胃酸的机会被最小化,因为胃中没有游离cooh组。前药的活性药物在胃中的生物转化需要一段时间,然后全部进入十二指肠,然后进入小肠回肠,从而减少了酸性的机会。最后,所有的前药都进入小肠,在那里开始碱性pH值,因此胃酸减少。由于这两种前药都是由两种非甾体抗炎药组成的:前药a (logP=2.15)释放阿司匹林和扑热息痛,前药b (logP=3.94)释放吲哚美辛和扑热息痛,在酸水解和碱水解的HPLC中显示出明显的两个Rt值,并且前药的这些Rt值与单个API成分相匹配,因此我们的目标已经成功完成。胃酸在人胃腔内的pH值在1.5- 3.5之间变化,酸度由质子泵H+/K+ atp酶维持。因此,在pH=3- 3.5时,用HCl调节酸水解模式。肠道的pH值在5.6-6.9之间变化,因此在pH=7.0-8.0时,NaOH调节了碱性水解的模式。如果是由两个原料药之间的氢键、离子相互作用、范德华相互作用、π相互作用等非共价相互作用形成的共药,由于前药是由两个原料药之间的共价键形成的,所以无论在酸性还是碱性条件下,母体分子的释放都会比前药快。log P剖面:Codrug-B (3.42); Codrug-A (1.55);分子量谱:Codrug-B (508.94g)和Codrug-A (331.31g)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信